In this episode, Lance Alstodt, CEO of BioRestorative Therapies, talks about their innovative stem cell therapies targeting chronic pain and metabolic disorders. They discuss the company's technology, clinical trials, market potential, and future plans, providing insights into regenerative medicine and biotech investment strategies.BioRestorative Therapies - <a rel="noopener noreferrer nofollow" href="https://biorestorative.com/" target="_blank">https://biorestorative.com/</a>Nano Cap Pod Website - <a rel="noopener noreferrer nofollow" href="https://www.nanocappod.com/" target="_blank">https://www.nanocappod.com/</a>DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

On the Nano Cap Podcast, we dive into the unique world of publicly traded companies with a market capitalization under $50 million – the nano caps. These are not just numbers on a stock ticker; they are stories of ambition, struggle, and triumph.

Each episode, I'll sit down with the leaders and visionaries behind these companies. We’ll uncover the challenges they face, the innovations they bring, and the strategies that drive them forward in a competitive market.